Latest Sironax News & Updates

See the latest news and media coverage for Sironax. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Sironax

Biotech developing therapies for degenerative diseases

sironax.com
Headquarters
Waltham, United States
Founded year
2017
Company type
Private company
Number of employees
60–200

Latest news about Sironax

Company announcements

  • Sironax

    Sironax announces SIR2501 abstract acceptance for ASCO 2026

    They will present insights on this clinical-stage SARM1 inhibitor as a potential treatment for chemotherapy-induced peripheral neuropathy.

  • Sironax

    Sironax appoints Clive Wang to Board of Directors

    Clive Wang, Managing Director at YF Capital, brings extensive life sciences investment experience. Dr. Shefali Agarwal praises his addition as the company advances clinical programs.

  • Sironax

    Sironax appoints two senior vice presidents

    Nasir Khan joins as SVP, Preclinical Development effective 2025-10-20 and Gary Ingenito as SVP, Clinical Development effective 2025-11-01. Both report to CEO Shefali Agarwal in Waltham.

  • Sironax

    Sironax named to 2025 Endpoints 11 list

    Endpoints News honors Sironax for discipline, strategic focus, and growth potential. The company was recognized at a Boston gala on Sept. 18, 2025.

Unlock all announcements with a

Media coverage

  • PR Newswire

    CONCEPT MEDICAL ANNOUNCES 3-YEAR PRELIMINARY DATA FROM SIRONA AT THE CHARING CROSS 2026 SYMPOSIUM

    /PRNewswire/ -- Concept Medical Inc., announced today the presentation of preliminary data from the 3-year follow-up of the randomized SIRONA trial at...

  • Pharmaphorum

    Chinese biotech Sironax raises $200m for RIPK1 pipeline

    Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors...

  • BioSpace

    Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting - BioSpace

    WALTHAM, Mass., April 22, 2026 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare...

Unlock all articles with a

Never miss news about Sironax

Track Sironax and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sironax competitors & trending companies

Browse news for competitors to Sironax and other trending companies.